Trial search
search
reset
more
Public title
Scientific title
Subject ID
Registration Status
Registration number
Secondary ID
Applicant
Study leader
Year
Primary sponsor
Secondary sponsor
Source(s) of funding
Target disease
Target disease code
Study type
Study phase
Study design
Recruiting status
Execute time(From)
Execute time(END)
Sign the informed consent
Gender
Nation(Area)
Province
City
Unit (hospital)
Institution
Level of the institution
Intervention
Intervention code
Approved by ethic committee
Calculated Results after the Study Completed puboptionc access
6 trials have been registered
Historical versions Registration number Public title Type Registration time
Historical Versions ChiCTR2000040181 Camrelizumab combine with gemcitabine and apatinib in the treatment of advanced PD-L1 positive Biliary tract cancer: A Single-arm, open, exploratory clinical study

Jiangsu Provincial People's Hospital

Interventional study 2020/11/24
Historical Versions ChiCTR1900020912 Phase II Clinical Study for Anlotinib Combined with Gemcitabine in the Treatment of Recurrent or Metastatic Advanced Cervical Cancer

The First People's Hospital of Yueyang

Interventional study 2019/01/22
Historical Versions ChiCTR-OPC-17012318 A cohort study for assessment of efficacy, safety and economic of the maintenance treatment of non-small cell lung cancer with qi deficiency and phlegm stasis syndrome

Guanganmen Hospital of Chinese Academy of traditional Chinese Medicine

Observational study 2017/08/09
Historical Versions ChiCTR-IPR-17010749 Study of Gemcitabine and Carboplatin in the postoperative adjuvant therapy of Cholangiocarcinoma

Peking Union Medical College Hospital

Interventional study 2017/02/28
Historical Versions ChiCTR-IPR-15006946 Clinical research on the safety and efficacy of iAPDA-DC/CTL treatment on malignant tumor of digestive system (mainly in biliary system and pancreas)

Changhai Hospital

Interventional study 2015/08/20
Historical Versions ChiCTR-TRC-09000477 A randomized control trial on the postoperative application of gemcitabine in patients with radical resection of biliary tract cancers

Sun Yet-sen Memorial Hospital of Sun Yet-sen University

Interventional study 2009/08/03